Download MammoVision

INTEGRATED
HEALTH
SCREENING
LTD
MammoVision™
Breast cancer is the most common malignant disease
in women. Traditional diagnostic methods for breast
cancer usually detect established disease, but fail to
spot the initial phase of disease development. Before
a lump is detected by mammography or ultrasound,
the cancer could have been developing for as long as
10 years.
One innovative technology which can help to fill this
gap is Infrared Regulation Imaging as used in
MammoVision™.
Developed
by
InfraMedic™,
Germany’s cutting edge medical infrared technology
company, with government research grants, and
proven in practical use worldwide, MammoVision™
is a screening tool to aid in the early detection,
prevention and management of breast cancer.
The thermal camera is a state-of-the-art system from
Jenoptik (formerly Carl Zeiss Jena) similar to nightvision systems used by the military. It is coupled to a
computer running dedicated software that analyses
and compares the images.
MammoVision™ uses no radiation, no needles, no
contact — just a set of thermal “photographs”. These
are stored in a computer and can be compared to
later examinations, allowing us to pick up any
changes. This means MammoVision™ can be used
to follow up suspect lesions, and to monitor progress
after treatment.
MammoVision™
is EU-certified (CE 0483) for
medical thermography, and is a class 1 medical
device, with the ability to accurately measure
temperature. It meets all the required specifications
for accuracy and reproducibility as well as all relevant
European directives on health and safety.
MammoVision™ assesses temperature changes
during the examination and provides a rating from 0
(no evidence of risk) to 5 (clear risk of serious breast
disease). Based on this information, and the person’s
history
and
personal
risk
factors,
further
investigation eg ultrasound or MRI may be advised.
Innovative Solutions for
Health and Prevention
Litfield House
Our Bristol centre is at:
Litfield House Medical Centre
1 Litfield Place,
Clifton, Bristol,
BS8 3LS
Telephone +44 (0) 117 317 1460
Email [email protected]
www.drhembry.com
Contact us for more information
Complementary breast screening
service, including
MammoVision™ thermal imaging,
screening tests for circulating tumour
cells and Specialist referral
IMAGES ARE TAKEN AND DOWNLOADED TO
COMPUTER
THE SOFTWARE CHARTS A GRID ON THE IMAGE
FOR COMPARISON WITH FUTURE IMAGES
RESULTS ARE ANALYSED BY SECTOR AND A
DETAILED REPORT MADE
Who are we?
Follow-up investigations
Infrared Regulation Imaging studies how your body
adapts to temperature change. You will be asked to
remove clothing from the top half of your body only,
and to take up a defined position on a chair. A
series of thermal images are taken from a distance
of 1 metre. Then you will wait in a controlled
temperature of 20º C (cool but comfortable) for 10
minutes and another set of images are taken. The
change in heat pattern allows “hot spots” due to, for
instance, suspect lumps, to show up.
The images are downloaded to computer in real-time
and stored, so comparison with follow-up tests in a
year or more is easy - and reliable. The computer
places a grid over the breast and analyses the
images segment by segment. For follow-up it
compares new and previous images by segment.
This patented grid system makes MammoVision the
first IR system capable of 100%-reproducible analysis
and therefore accurate comparative data of scans,
over time, of individual breast heat patterns.
All results will be assessed by our doctor, in
conjunction with detailed information from a health
questionnaire which you will be asked to complete
before your appointment. A comprehensive report will
then be sent to you advising on the test result and the
doctor’s
findings,
and
offering
additional
recommendations for lifestyle and diet measures.
We recommend following low-risk results by a repeat
examination, lifestyle suggestions and advice on selfexamination; higher risk results by additional
imaging and referral to our Breast Specialist for
further examination and investigations as necessary.
MammoVision thermal imaging is a form of ‘risk
assessment’. By assessing abnormal physiology, as
it relates to the changes that occur when a cancer
develops, it can provide an indication of the ‘risk’ of
breast cancer developing. High risk cases should
therefore be followed up to exclude or confirm the
presence of a tumour
Screening tests for circulating tumour cells
IHS Ltd also offers blood tests for circulating tumour
cells, including a specific assay for breast cancer
cells. This can be used as an adjunctive tool to aid in
the early diagnosis of breast cancer. Conventional
imaging picks up tumours of >0.5cm diameter,
generally missing smaller tumours. However, from
2mm diameter a tumour needs its own blood supply
to grow, and tumour cells can start being released
into the circulation at this point.
This additional information can therefore aid in the
diagnosis of early disease.
Please contact us for further information
Dr Nicola Hembry: BSc MB BS MSB
Is the director of Integrated Health Screening Ltd. She
is an experienced integrated medicine physician with
a particular interest in complementary and supportive
approaches to cancer
She works closely with InfraMedic™ in Germany, and
is a member of the European Thermographic
Association
The IHS team also includes:
Mr Zenon Rayter: respected Bristol breast surgeon.
Dr Lyn Jones: radiologist with a special interest in
breast imaging
For cancer patients – Dr Hembry also offers minimal
residual disease screening and chemosensitivity
testing. These specialised tests can help in the early
detection of a cancer recurrence, and also offer
guidance on which treatments may be most effective.
For further information www.drhembry.com